BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2017
View Archived Issues
Lin Bioscience licenses microtubule-targeting agent for brain cancer from University of Sydney
Read More
FDA accepts IND for phase I trials of TX-803 for colorectal cancer
Read More
Galapagos begins phase I study of cystic fibrosis potentiator GLPG-3067 under AbbVie collaboration
Read More
Fixed-dose combination tablets containing ertugliflozin show promise for type 2 diabetes
Read More
Preliminary results from malignant pleural mesothelioma cohort of KEYNOTE-028 study
Read More
Intec initiates phase I trial of AP-CBD/THC
Read More
FDA grants fast track designation to SHP-655 for hereditary thrombotic thrombocytopenic purpura
Read More
FDA clears Akashi to resume clinical development of HT-100
Read More
FDA grants orphan drug designation to avacopan for C3 glomerulopathy
Read More
Promising phase III data presented for alirocumab at ACC
Read More
Aveo initiates phase I/II trial of tivozanib and nivolumab in renal cell carcinoma
Read More
Achillion Pharmaceuticals patents complement factor D inhibitors
Read More
Eli Lilly and Company discloses new histone-lysine N-methyltransferase EZH2 inhibitors
Read More
Bayer Pharma discovers coagulation factor XIa and kallikrein inhibitors
Read More
Lilly initiates phase I trial of LY-3192767 in healthy subjects
Read More
Shenzhen Qingyaqirui Bio-Tech identifies new conjugates of memantine and arctigenin
Read More
Danish clearance for Oncology Venture's study of APO-010 in multiple myeloma
Read More
HitGen announces research collaboration with Merck & Co.
Read More
Bristol-Myers Squibb divulgues myeloperoxidase and/or eosinophil peroxidase inhibitors
Read More
FDA grants orphan drug designation for Toleranzia's TOL-2
Read More
Cue Biopharma selects lead candidate Cue-101 targeting HPV-associated cancers
Read More
Aprea collaborates with Memorial Sloan Kettering to study p53 reactivation by APR-246
Read More
Sunesis submits responses to EMA for vosaroxin MAA review
Read More
Alexion seeks Japanese approval of Soliris in refractory AChR-positive generalized myasthenia gravis
Read More
Phase II seizure data on UX-007 in patients with glucose transporter type-1 deficiency syndrome
Read More
